Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?
Pol Arch Med Wewn
2009; 119: 469–77.
Von Korff M, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, et al.
De facto long-term opioid therapy for noncancer pain. Clin J Pain
2008; 24: 521–7.
Scherrer JF, Salas J, Copeland LA, Stock EM, Ahmedani BK, Sullivan MD, et al.
Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Ann Fam Med
2016; 14: 54–62.
Vanderlip ER, Sullivan MD, Edlund MJ, Martin BC, Fortney J, Austen M, et al.
National study of discontinuation of long-term opioid therapy among veterans. Pain
2014; 155: 2673–94.
Martin BC, Fan MY, Edlund MJ, Devries A, Brennan-Braden J, Sullivan MD.
Long-term chronic opioid therapy discontinuation rtes from the TROUP study. J Gen Intern Med
2011; 26: 1450–7.
Scherrer JF, Salas J, Sullivan MD, Schneider FD, Bucholz KK, Burroughs T, et al.
The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med
2016; 91: 110–6.
Scherrer JF, Svrakic DM, Freedland KE, Chrusciel T, Balasubramanian S, Bucholz KK, et al.
Prescription opioid analgesics increase the risk of depression. J Gen Intern Med
2014; 29: 491–9.
Why does depression promote long-term opioid use?
2016; 157: 2395–6.
Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, et al.
Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA
2009; 301: 2099–110.
Kroenke K, Wu J, Bair MJ, Krebs EE, Damush TM, Tu W.
Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain
2011; 12: 964–73.
Vowles KE, Witkiewitz K, Levell J, Sowden G, Ashworth J.
Are reductions in pain intensity and pain-related distress necessary? An analysis of within-treatment change trajectories in relation to improved functioning following interdisciplinary acceptance and commitment therapy for adults with chronic pain. J Consult Clin Psychol
2017; 85: 87–98.
Ho SC, Chong HY, Chaiyakunapruk N, Tangiisuran B, Jacob SA.
Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord
2016; 193: 1–10.
Akerblad AC, Bengtsson F, von Knorring L, Ekselius L.
Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study. Int Clin Psychopharmacol
2006; 21: 117–24.
Kroenke K, Spitzer RL, Williams JB.
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med
2001; 16: 606–13.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD–9). WHO, 1978.
Frayne SM, Miller DR, Sharkansky EJ, Jackson VW, Wang F, Halanych JH, et al.
Using administrative data to identify mental illness: what approach is best?
Am J Med Qual
2010; 25: 42–50.
Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O'Connor PG.
Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease and depression. Am J Med Qual
2006; 21: 238–45.
National Committee for Quality Assurance. The State of Health Care Quality. National Committee for Quality Assurance, 2013.
Hess LM, Raebel MA, Conner DA, Malone DC.
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother
2006; 40: 1280–8.
Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al.
Medication compliance and persistence: terminology and definitions. Value Health
2008; 11: 44–7.
Quinn PD, Hur K, Chang Z, Krebs EE, Bair MJ, Scott EL, et al.
Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain
2017; 158: 140–8.
Physical Consequences of Depression. Wrightson Biomedical Publishing, 2001.
Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, et al.
Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA
2012; 307: 940–7.
Correa D, Farney RJ, Chung F, Prasad A, Lam D, Wong J.
Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations. Anesth Analg
2015; 120: 1273–85.
O'Rourke TK Jr, Wosnitzer MS.
Opioid-induced androgen deficiency (OPIAD): diagnosis, management, and literature review. Curr Urol Rep
2016; 17: 76.
Dobscha SK, Morasco BJ, Kovas AE, Peters DM, Hart K, McFarland BH.
Short-term variability in outpatient pain intensity scores in a national sample of older veterans with chronic pain. Pain Med
2015; 16: 855–65.
Cole SR, Hernan MA.
Constructing inverse probability weights for marginal structural models. Am J Epidemiol
2008; 168: 656–64.
Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, Anstrom KJ.
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care
2007; 45 (10 Supl 2): S103–7.
Harder VS, Stuart EA, Anthony JC.
Propsensity score techinques and the assessment of measure covariate balance to test causal associations in psychological research. Psychol Methods
2010; 15: 234–49.
Kilpatrick RD, Gilbertson D, Brookhart MA, Polley E, Rothman KJ, Bradbury BD.
Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rate treatment decisions. Pharmacoepidemiol Drug Saf
2013; 22: 111–21.
Rosenbaum PR, Rubin DB.
The central role of the prospensity score in observational studies for causal effects. Biometrika
1983; 70; 41–55.
Xu S, Ross C, Raebel MA, Shetterly S, Blanchette C, Smith D.
Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health
2010; 13: 273–7.
Austin P, Stuart E.
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med
2015; 34: 3661–79.
Sturmer T, Wyss R, Glynn RJ, Brookhart MA.
Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med
2014; 275: 570–80.
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med
2009; 28: 3083–107.
Howe CQ, Sullivan MD.
The missing ‘P’ in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care. Gen Hosp Psychiatry
2014; 36: 99–104.
Berna C, Kulich RJ, Rathmell JP.
Tapering long term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice. Mayo Clin Proc
2015; 90: 828–42.
Bitton A, Choudhry NK, Matlin OS, Swanton K, Shrank WH.
The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med
2013; 126: 357.e7–e27.
Scherrer JF, Salas J, Copeland LA, Stock EM, Schneider FD, Sullivan M, et al.
Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain
2016; 17: 473–82.
Skljarevski V, Desaiah D, Liu-Seifert H, Zhang Q, Chappell AS, Detke MJ, et al.
Efficacy and safety of duloxetine in patients with chronic low back pain. Spine
2010; 35: E578–E85.
Atkinson JH, Patel SM, Meyer JM, Slater MA, Zisook S, Capparelli E.
Is there a therapeutic window with some antidepressants for analgesic response?
Curr Pain Headache Rep
2009; 13: 93–9.